BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9309765)

  • 1. The current status of antiparasite chemotherapy.
    Croft SL
    Parasitology; 1997; 114 Suppl():S3-15. PubMed ID: 9309765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Target points of antiparasitic drugs].
    Boczoń K
    Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
    [No Abstract]   [Full Text] [Related]  

  • 3. Parasite proteinases and amino acid metabolism: possibilities for chemotherapeutic exploitation.
    Coombs GH; Mottram JC
    Parasitology; 1997; 114 Suppl():S61-80. PubMed ID: 9309769
    [No Abstract]   [Full Text] [Related]  

  • 4. A structure-based approach to drug discovery; crystallography and implications for the development of antiparasite drugs.
    Hunter WN
    Parasitology; 1997; 114 Suppl():S17-29. PubMed ID: 9309766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for parasitic infections.
    Med Lett Drugs Ther; 1990 Mar; 32(814):23-32. PubMed ID: 2179697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating targets for antiparasite chemotherapy.
    Wang CC
    Parasitology; 1997; 114 Suppl():S31-44. PubMed ID: 9309767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological approaches towards rationalizing the use of endoparasitic drugs in small animals.
    Sanchez Bruni SF; Jones DG; McKellar QA
    J Vet Pharmacol Ther; 2006 Dec; 29(6):443-57. PubMed ID: 17083448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
    Biñas M; Johnson AM
    Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leads.
    Austin SE; Khan MO; Douglas KT
    Drug Des Discov; 1999 Jul; 16(1):5-23. PubMed ID: 10466053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of protozoal and helminthic diseases of the gastrointestinal system in Israel].
    El-On J; Karsenty E
    Harefuah; 1984 Nov; 107(10):298-308. PubMed ID: 6530176
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
    McKerrow JH
    Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New antifungal and antiparasitic molecules].
    Esterre P; Jamet P
    Med Trop (Mars); 1987; 47(1):47-52. PubMed ID: 3586972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzimidazole resistance in helminths: From problem to diagnosis.
    Furtado LFV; de Paiva Bello ACP; Rabelo ÉML
    Acta Trop; 2016 Oct; 162():95-102. PubMed ID: 27338184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
    Hammarton TC; Mottram JC; Doerig C
    Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer drugs: pipe-dreams or realities?
    Gutteridge WE
    Parasitology; 1997; 114 Suppl():S145-51. PubMed ID: 9309776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroheterocyclic drugs with broad spectrum activity.
    Raether W; Hänel H
    Parasitol Res; 2003 Jun; 90 Supp 1():S19-39. PubMed ID: 12811546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic schemes in the most common enteroparasitoses in Chile].
    Atías A
    Bol Chil Parasitol; 1971; 26(1):36-43. PubMed ID: 5130183
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity.
    Hudson AT; Randall AW; Fry M; Ginger CD; Hill B; Latter VS; McHardy N; Williams RB
    Parasitology; 1985 Feb; 90 ( Pt 1)():45-55. PubMed ID: 3920634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medicinal Chemistry of some "exotics". Agents against worm and protozoal diseases, and the antiviral ribavirin].
    Schlitzer M; Ortmann R; Form I
    Pharm Unserer Zeit; 2010; 39(1):18-26. PubMed ID: 20033938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.